PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Applied DNA Sciences, Inc. (APDN)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US03815U3005

CUSIP

03815U300

Sector

Healthcare

IPO Date

Jul 15, 2003

Highlights

Market Cap

$9.03M

EPS (TTM)

-$0.65

Total Revenue (TTM)

$3.74M

Gross Profit (TTM)

$1.28M

EBITDA (TTM)

-$12.80M

Year Range

$0.12 - $14.40

Target Price

$1.50

Short %

19.30%

Short Ratio

1.69

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
APDN vs. VOO
Popular comparisons:
APDN vs. VOO

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Applied DNA Sciences, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-100.00%
9.31%
APDN (Applied DNA Sciences, Inc.)
Benchmark (^GSPC)

Returns By Period

Applied DNA Sciences, Inc. had a return of -19.75% year-to-date (YTD) and -98.80% in the last 12 months. Over the past 10 years, Applied DNA Sciences, Inc. had an annualized return of -62.61%, while the S&P 500 had an annualized return of 11.31%, indicating that Applied DNA Sciences, Inc. did not perform as well as the benchmark.


APDN

YTD

-19.75%

1M

-14.47%

6M

-92.09%

1Y

-98.80%

5Y*

-70.47%

10Y*

-62.61%

^GSPC (Benchmark)

YTD

4.46%

1M

2.46%

6M

9.31%

1Y

23.49%

5Y*

13.03%

10Y*

11.31%

*Annualized

Monthly Returns

The table below presents the monthly returns of APDN, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-14.17%-19.75%
2024-6.37%0.66%-29.47%-51.22%-85.10%-31.45%-7.93%407.98%-65.98%-72.06%-16.14%34.03%-98.35%
2023-10.84%-5.41%-19.29%-14.16%13.40%17.27%35.66%-26.86%-5.47%-38.02%17.33%-29.91%-62.84%
2022-17.91%-22.42%-16.41%-25.23%-19.38%-42.78%-3.87%339.68%-63.78%57.52%-23.60%22.06%-58.71%
2021118.43%-19.66%-19.66%-4.45%-15.72%17.27%-20.77%8.92%-8.02%-0.19%7.43%-30.45%-21.18%
2020-9.55%5.28%0.75%71.14%41.28%-16.98%23.92%-26.70%5.46%-0.26%-2.46%-32.18%21.72%
201910.78%51.95%5.82%-17.18%-0.54%-14.81%-40.36%2.28%-26.72%-22.58%-39.61%0.24%-73.81%
2018-4.40%-4.61%-0.69%4.86%-1.32%-15.44%9.52%-11.59%22.13%-26.17%0.00%-63.64%-74.84%
2017-2.70%2.78%-10.81%6.06%-25.71%35.38%-1.70%19.65%38.65%-25.78%9.86%-32.05%-14.05%
2016-1.23%-10.31%19.86%-12.50%-2.66%10.24%6.19%-6.71%-4.69%-8.20%-21.43%-15.91%-42.90%
201519.03%13.08%-33.42%2.70%-2.63%19.69%-15.81%36.78%43.42%-32.81%-12.79%8.00%12.11%
2014-12.29%-1.82%-10.06%-8.73%4.26%1.83%-5.81%-4.35%-17.27%9.71%-61.60%25.65%-70.40%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of APDN is 10, meaning it’s performing worse than 90% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of APDN is 1010
Overall Rank
The Sharpe Ratio Rank of APDN is 2323
Sharpe Ratio Rank
The Sortino Ratio Rank of APDN is 66
Sortino Ratio Rank
The Omega Ratio Rank of APDN is 66
Omega Ratio Rank
The Calmar Ratio Rank of APDN is 11
Calmar Ratio Rank
The Martin Ratio Rank of APDN is 1717
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Applied DNA Sciences, Inc. (APDN) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for APDN, currently valued at -0.43, compared to the broader market-2.000.002.00-0.431.74
The chart of Sortino ratio for APDN, currently valued at -1.38, compared to the broader market-4.00-2.000.002.004.006.00-1.382.35
The chart of Omega ratio for APDN, currently valued at 0.82, compared to the broader market0.501.001.502.000.821.32
The chart of Calmar ratio for APDN, currently valued at -0.99, compared to the broader market0.002.004.006.00-0.992.61
The chart of Martin ratio for APDN, currently valued at -1.14, compared to the broader market0.0010.0020.0030.00-1.1410.66
APDN
^GSPC

The current Applied DNA Sciences, Inc. Sharpe ratio is -0.43. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Applied DNA Sciences, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00SeptemberOctoberNovemberDecember2025February
-0.43
1.74
APDN (Applied DNA Sciences, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Applied DNA Sciences, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-100.00%
0
APDN (Applied DNA Sciences, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Applied DNA Sciences, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Applied DNA Sciences, Inc. was 100.00%, occurring on Dec 2, 2024. The portfolio has not yet recovered.

The current Applied DNA Sciences, Inc. drawdown is 100.00%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-100%Nov 26, 20035268Dec 2, 2024
-10.91%Aug 7, 200331Oct 2, 200317Oct 27, 200348
-8.73%Jul 25, 20032Jul 28, 20035Aug 4, 20037
-7.5%Oct 30, 20036Nov 6, 20032Nov 10, 20038
-4.64%Nov 17, 20034Nov 20, 20033Nov 25, 20037

Volatility

Volatility Chart

The current Applied DNA Sciences, Inc. volatility is 22.08%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%100.00%120.00%SeptemberOctoberNovemberDecember2025February
22.08%
3.07%
APDN (Applied DNA Sciences, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Applied DNA Sciences, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Applied DNA Sciences, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab